Literature DB >> 20186396

The effect of a functional NOS1 promoter polymorphism on impulsivity is moderated by platelet MAO activity.

Kariina Laas1, Andreas Reif, Sabine Herterich, Diva Eensoo, Klaus-Peter Lesch, Jaanus Harro.   

Abstract

RATIONALE: Platelet monoamine oxidase (MAO) activity is associated with impulsivity in clinical samples. Recently, a functional promoter polymorphism of neuronal nitric oxide synthase (NOS1) termed NOS1 ex1f-VNTR was found to have an effect on impulsivity-related traits and resulting psychopathology.
OBJECTIVE: The study aims to explore the effect of both platelet MAO activity and NOS1 ex1f-VNTR genotype on impulsivity in a population-derived sample.
METHODS: This study was on a non-clinical sample of adult male subjects, previously used to investigate the effect of platelet MAO activity on impulsivity-related behaviour (Paaver et al., Psychopharmacology 186:32-40, 2006). Six hundred thirty-seven male subjects were genotyped for the NOS1 ex1f-VNTR promoter polymorphism. Impulsivity was self-reported. Effects of age and smoking, known to affect platelet MAO activity, were controlled for.
RESULTS: No main effect of either NOS1 genotype or platelet MAO activity was present. However, significant interactions were found between effects of the NOS1 genotype and platelet MAO activity on impulsivity measures. Impulsivity and in particular the aspects of adaptive impulsivity (e.g. fast decision-making and excitement-seeking behaviour) were higher in subjects with the NOS1 ex1f-VNTR short/short genotype if they belonged to the platelet MAO medium activity (interquartile) range.
CONCLUSIONS: This study supports evidence for higher impulsivity in the NOS1 short/short genotype subjects and further suggests that this is present in the subset of subjects who have close to average platelet MAO activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186396     DOI: 10.1007/s00213-010-1793-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

Review 1.  Platelet monoamine oxidase, personality and alcoholism: the rise, fall and resurrection.

Authors:  Lars Oreland
Journal:  Neurotoxicology       Date:  2004-01       Impact factor: 4.294

2.  Transcription of human neuronal nitric oxide synthase mRNAs derived from different first exons is partly controlled by exon 1-specific promoter sequences.

Authors:  Matthias Bros; Jean-Paul Boissel; Ute Gödtel-Armbrust; Ulrich Förstermann
Journal:  Genomics       Date:  2006-01-18       Impact factor: 5.736

3.  Functional and dysfunctional impulsivity: personality and cognitive correlates.

Authors:  S J Dickman
Journal:  J Pers Soc Psychol       Date:  1990-01

Review 4.  Toward a neurogenetic theory of neuroticism.

Authors:  Turhan Canli
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

Review 5.  Nitric oxide: a novel link between synaptic and nonsynaptic transmission.

Authors:  J P Kiss; E S Vizi
Journal:  Trends Neurosci       Date:  2001-04       Impact factor: 13.837

6.  Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in Eastern Quebec families.

Authors:  M Maziade; M-A Roy; Y C Chagnon; D Cliche; J-P Fournier; N Montgrain; C Dion; J-C Lavallée; Y Garneau; N Gingras; L Nicole; A Pirès; A-M Ponton; A Potvin; H Wallot; C Mérette
Journal:  Mol Psychiatry       Date:  2005-05       Impact factor: 15.992

7.  Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals.

Authors:  T Wultsch; S Chourbaji; S Fritzen; S Kittel; E Grünblatt; M Gerlach; L Gutknecht; F Chizat; G Golfier; A Schmitt; P Gass; K P Lesch; A Reif
Journal:  J Neural Transm Suppl       Date:  2007

8.  Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity.

Authors:  B Chanrion; C Mannoury la Cour; F Bertaso; M Lerner-Natoli; M Freissmuth; M J Millan; J Bockaert; P Marin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-23       Impact factor: 11.205

9.  Nature and nurture predispose to violent behavior: serotonergic genes and adverse childhood environment.

Authors:  Andreas Reif; Michael Rösler; Christine M Freitag; Marc Schneider; Andrea Eujen; Christian Kissling; Denise Wenzler; Christian P Jacob; Petra Retz-Junginger; Johannes Thome; Klaus-Peter Lesch; Wolfgang Retz
Journal:  Neuropsychopharmacology       Date:  2007-03-07       Impact factor: 7.853

Review 10.  Concepts of neural nitric oxide-mediated transmission.

Authors:  John Garthwaite
Journal:  Eur J Neurosci       Date:  2008-06       Impact factor: 3.386

View more
  4 in total

1.  A functional NOS1 promoter polymorphism interacts with adverse environment on functional and dysfunctional impulsivity.

Authors:  Andreas Reif; Evelyn Kiive; Triin Kurrikoff; Marika Paaver; Sabine Herterich; Kenn Konstabel; Tiia Tulviste; Klaus-Peter Lesch; Jaanus Harro
Journal:  Psychopharmacology (Berl)       Date:  2010-06-30       Impact factor: 4.530

2.  Evidence for the contribution of NOS1 gene polymorphism (rs3782206) to prefrontal function in schizophrenia patients and healthy controls.

Authors:  Zhifang Zhang; Xiongying Chen; Ping Yu; Qiumei Zhang; Xiaochen Sun; Huang Gu; Hao Zhang; Jinguo Zhai; Min Chen; Boqi Du; Xiaoxiang Deng; Feng Ji; Chuanyue Wang; Yutao Xiang; Dawei Li; Hongjie Wu; Jun Li; Qi Dong; Chuansheng Chen
Journal:  Neuropsychopharmacology       Date:  2014-12-10       Impact factor: 7.853

Review 3.  Gene-environment studies and borderline personality disorder: a review.

Authors:  Ryan W Carpenter; Rachel L Tomko; Timothy J Trull; Dorret I Boomsma
Journal:  Curr Psychiatry Rep       Date:  2013-01       Impact factor: 5.285

4.  A Functional Vesicular Monoamine Transporter 1 (VMAT1) Gene Variant Is Associated with Affect and the Prevalence of Anxiety, Affective, and Alcohol Use Disorders in a Longitudinal Population-Representative Birth Cohort Study.

Authors:  Mariliis Vaht; Evelyn Kiive; Toomas Veidebaum; Jaanus Harro
Journal:  Int J Neuropsychopharmacol       Date:  2016-07-05       Impact factor: 5.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.